SCHEMBL755454

SCHEMBL755454

CCC(CC(Br)C(=O)O)C(Br)(CC)C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.35
PPARD Q03181 1/20 0.35
ZDHHC20 Q5W0Z9 1/20 0.35
ZDHHC2 Q9UIJ5 1/20 0.35
ALDH1A1 P00352 1/20 0.34
TSHR P16473 1/20 0.34
KIF11 P52732 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17669538 0.84 LCK (0.42) LCKPPARDZDHHC20ZDHHC2ALDH1A1
SCHEMBL5071332 0.81 LCK (0.47) LCKPPARDZDHHC20ZDHHC2ALDH1A1
SCHEMBL31430102 0.76 SLC22A6 (0.31) ALDH1A1
SCHEMBL28392033 0.70 GRM2 (0.31) LCKPPARDZDHHC20ZDHHC2ALDH1A1
SCHEMBL28335670 0.69 ALDH1A1 (0.48) LCKPPARDZDHHC20ZDHHC2ALDH1A1
SCHEMBL9714801 0.69 FFAR4 (0.42) PPARDALDH1A1TSHR
SCHEMBL1024524 0.68
SCHEMBL17822467 0.68
SCHEMBL1733291 0.68 CYP1A2 (0.33) ALDH1A1
SCHEMBL1000119 0.68 CYP1A2 (0.33) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12614739-B2 Member for fuel cell and method for manufacturing same SUMITOMO RIKO COMPANY LIMITED (JP) 2026-04-28 US disclosed
EP-4660211-A1 COMPOSITION FOR TEMPORARY FIXATION, ADHESIVE FOR TEMPORARY FIXATION, AND METHOD FOR PRODUCING THIN WAFER Denka Company Limited (JP) 2025-12-10 EP disclosed
WO-2024162053-A1 COMPOSITION FOR TEMPORARY FIXATION, ADHESIVE FOR TEMPORARY FIXATION, AND METHOD FOR PRODUCING THIN WAFER デンカ株式会社 2024-08-08 WO disclosed
US-12009555-B2 Radical-curable seal member for fuel cell SUMITOMO RIKO COMPANY LIMITED (JP) 2024-06-11 US disclosed
EP-4366003-A1 RADICAL-CURABLE SEALING MEMBER FOR FUEL CELLS Sumitomo Riko Company Limited (JP) 2024-05-08 EP disclosed
US-20240052176-A1 RADICAL-CURABLE SEALING MEMBER FOR FUEL CELLS SUMITOMO RIKO COMPANY LIMITED (JP) 2024-02-15 US disclosed
CN-117501485-A Radical curable sealing member for fuel cell 住友理工株式会社 2024-02-02 CN disclosed
CN-114008095-B Radical curable sealing member for fuel cell 住友理工株式会社 2023-08-04 CN disclosed
EP-3919533-B1 RADICAL-CURABLE SEAL MEMBER FOR FUEL CELL SUMITOMO RIKO CO LTD (JP) 2023-07-12 EP disclosed
US-20230207839-A1 MEMBER FOR FUEL CELL AND METHOD FOR MANUFACTURING SAME SUMITOMO RIKO COMPANY LIMITED (JP) 2023-06-29 US disclosed
US-20070276057-A1 Curing Composition Having Mold Releasability KANEKA CORPORATION (JP) 2007-11-29 US disclosed
US-20070276066-A1 Curing Composition KANEKA CORPORATION (JP) 2007-11-29 US disclosed
US-20070179249-A1 Curing composition KANEKA CORPORATION (JP) 2007-08-02 US disclosed
EP-1736467-A1 NOVEL SULFONAMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2006-12-27 EP disclosed
EP-1642932-A1 CURING COMPOSITION KANEKA CORPORATION (JP) 2006-04-05 EP disclosed
EP-1640391-A1 CURING COMPOSITION KANEKA CORPORATION (JP) 2006-03-29 EP disclosed
EP-1640392-A1 CURING COMPOSITION HAVING MOLD RELEASABILITY KANEKA CORPORATION (JP) 2006-03-29 EP disclosed
US-20040242790-A1 Polyolefin graft copolymer produced with coordination polymerization catalyst based on complex of transition metal appearing in later period and process for producing the same KANEKA CORPORATION (JP) 2004-12-02 US disclosed
EP-1440988-A1 POLYOLEFIN GRAFT COPOLYMER PREPARED IN THE PRESENCE OF COODINATION POLYMERIZATION CATALYST BASED ON LATE TRANSITION METAL COMPLEX AND METHOD FOR MAKING THE SAME KANEKA CORPORATION (JP) 2004-07-28 EP disclosed
US-20020137841-A1 Functional groups-terminated vinyl polymers KANEKA CORPORATION (JP) 2002-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12614739-B2 Member for fuel cell and method for manufacturing same FABP4, LIPC, LRBA LCK 4481/4885PPARD 2090/4885ZDHHC20 375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.